Status: Recruiting
A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II
This is phase 2/3 study to evaluate the safety, pharmacokinetics, pharmacodynamics, and efficacy of the investigational product GNR-055 in MPS II (Hunter syndrome) patients of different age groups.
Participants needed: 32
Trial details
Phase: Phase 2, Phase 3Biological sex: MaleType: InterventionalSponsor: AO GENERIUMUpdated: Jul 30, 2025Locations: 5
Eligibility criteria
Signed inform consent; [+4]
Clinically pronounced hypersensitivity to ID2S or any other component of the dru... [+3]